Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Two-arm, Randomized, Open, Phase II Study Investigating SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

NCT00991250 is registered in ClinicalTrials.gov with SentoClone AB as lead sponsor.

NCT NCT00991250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00991250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Two-arm, Randomized, Open, Phase II Study Investigating SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma
Lead sponsor
SentoClone AB
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2009
Completion date
September 30, 2011
Enrollment
140 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma